Announcements March 2006 Kyowa releases results to Phase III clinical studies of an anti-parkinson's disease drug istradefylline/ KW-6002 conducted overseas April 2004 Phase III clinical studies are being planned for anti-Parkinson's drug, KW-6002 September 2002 MedAdNews: Top 50 Pharma Kyowa Hakko Kogyo: Kyowa emerging February 18, 2002 Kyowa Hakko Has Obtained Encouraging Clinical Results in a New Approach to Treatment of Parkinson's Disease December 6, 2001 Phase II clinical study of an anti-cancer agent KW-2170 will start in five countries including the US August 7, 2001 Kyowa Pharmaceutical Inc. Chooses IntraLinks Pharma Company Uses Digital Workspaces to Streamline Drug Development June 6, 2001 KW-7158, a therapeutic agent for urinary incontinence, will enter Phase II in Europe April 25, 2001 Kyowa Hakko's vision of pharmaceutical business, "Reform for value creation"